Back to Search
NAJJIYYA ARNOLD, PHD CANDIDATE
PHD CANDIDATE
Psychologist
NPI: 1487636809Individual
Specialties, Licenses & Credentials
PsychologistPrimary
Psychologist
Code: 103T00000X
PSB94021376(CA)
Clinical Psychologist
Psychologist — Clinical
Code: 103TC0700X
PSB94021376(CA)
Group Psychotherapy Psychologist
Psychologist — Group Psychotherapy
Code: 103TP2701X
PSB94021376(CA)
Marriage & Family Therapist
Marriage & Family Therapist
Code: 106H00000X
IMF 73333(CA)
Research & Publications (20)
The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances gemcitabine-induced cell death in pancreatic cancer.
PMID 17200334·Clin Cancer Res·2007
7-preclinical
Potent and selective xanthine-based inhibitors of phosphodiesterase 5.
PMID 17337182·Bioorg Med Chem Lett·2007
7-preclinical
Thioredoxin is downstream of Smad7 in a pathway that promotes growth and suppresses cisplatin-induced apoptosis in pancreatic cancer.
PMID 15150118·Cancer Res·2004
8-other
Immunohistochemical expression of epithelial cell markers in corneas with congenital aniridia and ocular cicatrizing pemphigoid.
PMID 19558573·Acta Ophthalmol·2011
8-other
Identification of brain- and bone-specific breast cancer metastasis genes.
PMID 19114293·Cancer Lett·2009
8-other
Recurrent loss, but lack of mutations, of the SMARCB1 tumor suppressor gene in T-cell prolymphocytic leukemia with TCL1A-TCRAD juxtaposition.
PMID 19480937·Cancer Genet Cytogenet·2009
8-other
Prognostic value of human epidermal growth factor receptor 2 (Her-2)/neu in patients with advanced ovarian cancer treated with platinum/paclitaxel as first-line chemotherapy: a retrospective evaluation of the AGO-OVAR 3 Trial by the AGO OVAR Germany.
PMID 19258951·Int J Gynecol Cancer·2009
2-rct
Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker.
PMID 19115204·Int J Cancer·2009
8-other
Polymorphisms in BRCA2 resulting in aberrant codon-usage and their analysis on familial breast cancer risk.
PMID 19229607·Breast Cancer Res Treat·2009
8-other
GeneChip analyses point to novel pathogenetic mechanisms in mantle cell lymphoma.
PMID 19016712·Br J Haematol·2009
8-other
A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women.
PMID 19028706·Carcinogenesis·2009
8-other
Precise genome modification in the crop species Zea mays using zinc-finger nucleases.
PMID 19404259·Nature·2009
8-other
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers.
PMID 19656774·Hum Mol Genet·2009
4-observational
Reverse painting of microdissected chromosome 19 markers in ovarian carcinoma identifies a complex rearrangement map.
PMID 18973136·Genes Chromosomes Cancer·2009
8-other
Constituents of leaves and flowers essential oils of Helichrysum pallasii (Spreng.) Ledeb. growing wild in Lebanon.
PMID 19298217·J Med Food·2009
8-other
1-O-Substituted derivatives of murrayafoline A and their antifungal properties.
PMID 19023805·Nat Prod Res·2008
8-other
Plants used as remedies antirheumatic and antineuralgic in the traditional medicine of Lebanon.
PMID 18809483·J Ethnopharmacol·2008
8-other
An evaluation of the polymorphisms Ins16bp and Arg72Pro in p53 as breast cancer risk modifiers in BRCA1 and BRCA2 mutation carriers.
PMID 18781154·Br J Cancer·2008
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 8365 STONYBECK CIR, 7902 GERBER ROAD, SUITE 232
SACRAMENTO, CA 95828 - Phone
- (916) 705-6259
Quick Facts
- NPI
- 1487636809
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 4
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile